5Tomita F;Kohya T;Sakurai M.Prevalence and clinical characteristics of patients with atrial fibrillation:analysis of 20,000 cases in Japan[J],2000(09).
6Kannel WB;Wolf PA;Benjamin EJ.Prevalence,incidence,prognosis,and predisposing conditions for atrial fibrillation:population-based estimates,1998(8A).
4Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke : The Framingham Study [ J ]. Stroke, 1991,22 ( 8 ) :983 -988.
5Petersen P, Boysen G, Gootfredsen J, et al. Randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study [ J ]. Lancet, 1989,1 ( 8631 ) : 175 -179.
7The Boston area anticoagulation trial for atrial fibrillation investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation[ J]. N Engl J Med,1990,323(22) :1505-1511.
8Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators [ J]. N Engl J Med, 1990, 328 (2) : 148-152.
9Connolly SJ, Laupacis A, Canadian G. Atrial Fibrillation Anticoagulation ( CAFA ) study [ J ]. J Am Coll Cardiol, 1991,18 ( 2 ) : 349 -355.
10Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults : national implications for rhythm management and stroke prevention : the anticoagulation and risk factors in atrial fibrillation (ATRIA) study [J]. JAMA, 2001,285 ( 18 ) : 2370-2375.
